Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06836492 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06836492 · ClinicalTrials.gov record · last posted 2025-02-20

A Prospective Clinical Cohort Study on Stratified Treatment of Rhabdomyosarcoma Based on Risk Factors.

StatusRecruiting
PhasePhase 3
Started2017-01-30
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The purpose is to explore the efficacy and safety of the SYSUCC-RMS regimen for pediatric RMS patients and to explore the impact of concurrent radiotherapy and chemotherapy on the survival rate of low-risk, medium risk, high-risk, and extremely high-risk patients in children.
Trial Details
NCT Number NCT06836492
Lead Sponsor Yizhuo Zhang
Conditions Rhabdomyosarcoma, Pediatric Cancer
Enrollment 300 participants
Start Date 2017-01-30
Primary Completion 2029-09 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2025-02-20